PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,545,332 | -29.0% | 1,502,435 | +13.1% | 0.00% | -50.0% |
| Q2 2023 | $17,674,012 | +26.3% | 1,328,873 | +9.9% | 0.00% | 0.0% |
| Q1 2023 | $13,999,000 | +209528.6% | 1,208,876 | +48.1% | 0.00% | +100.0% |
| Q4 2022 | $6,678 | -99.8% | 816,421 | +13.7% | 0.00% | 0.0% |
| Q3 2022 | $4,168,000 | +21.1% | 717,924 | -7.8% | 0.00% | – |
| Q2 2022 | $3,441,000 | -62.8% | 778,424 | -23.4% | 0.00% | -100.0% |
| Q1 2022 | $9,244,000 | +69.1% | 1,015,819 | +280.2% | 0.00% | 0.0% |
| Q4 2021 | $5,467,000 | -13.8% | 267,189 | +7.7% | 0.00% | 0.0% |
| Q3 2021 | $6,341,000 | -39.4% | 248,137 | -17.0% | 0.00% | 0.0% |
| Q2 2021 | $10,457,000 | -46.7% | 299,014 | -49.2% | 0.00% | -66.7% |
| Q1 2021 | $19,602,000 | +237.6% | 588,491 | +162.9% | 0.00% | +200.0% |
| Q4 2020 | $5,807,000 | +852.0% | 223,851 | +259.9% | 0.00% | – |
| Q3 2020 | $610,000 | +260.9% | 62,199 | +27.1% | 0.00% | – |
| Q2 2020 | $169,000 | -94.9% | 48,940 | -95.5% | 0.00% | -100.0% |
| Q1 2020 | $3,330,000 | +114.8% | 1,088,146 | +260.9% | 0.00% | – |
| Q4 2019 | $1,550,000 | -5.9% | 301,473 | -5.6% | 0.00% | – |
| Q3 2019 | $1,648,000 | -12.3% | 319,384 | +2.1% | 0.00% | – |
| Q2 2019 | $1,880,000 | -70.3% | 312,816 | -64.3% | 0.00% | -100.0% |
| Q1 2019 | $6,332,000 | +214.2% | 875,710 | +221.6% | 0.00% | – |
| Q4 2018 | $2,015,000 | +912.6% | 272,309 | +640.0% | 0.00% | – |
| Q3 2018 | $199,000 | +126.1% | 36,801 | +48.8% | 0.00% | – |
| Q2 2018 | $88,000 | +41.9% | 24,740 | -17.8% | 0.00% | – |
| Q1 2018 | $62,000 | +5.1% | 30,101 | +34.6% | 0.00% | – |
| Q4 2017 | $59,000 | -51.6% | 22,357 | -35.0% | 0.00% | – |
| Q2 2017 | $122,000 | -76.5% | 34,370 | -65.8% | 0.00% | – |
| Q1 2017 | $519,000 | +3.8% | 100,410 | -23.6% | 0.00% | – |
| Q4 2016 | $500,000 | -46.4% | 131,461 | +26.3% | 0.00% | – |
| Q3 2016 | $933,000 | +141.7% | 104,079 | +89.5% | 0.00% | – |
| Q2 2016 | $386,000 | +53.8% | 54,910 | +85.7% | 0.00% | – |
| Q1 2016 | $251,000 | -53.1% | 29,564 | -27.3% | 0.00% | – |
| Q4 2015 | $535,000 | +1271.8% | 40,667 | +277.0% | 0.00% | – |
| Q3 2015 | $39,000 | -95.2% | 10,787 | -92.3% | 0.00% | – |
| Q1 2015 | $819,000 | +164.2% | 140,355 | +255.3% | 0.00% | – |
| Q4 2014 | $310,000 | +269.0% | 39,500 | +148.6% | 0.00% | – |
| Q4 2013 | $84,000 | -61.1% | 15,891 | -59.4% | 0.00% | – |
| Q3 2013 | $216,000 | +671.4% | 39,108 | +260.3% | 0.00% | – |
| Q2 2013 | $28,000 | – | 10,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |